Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Trial pipeline

Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.

Free access · No subscription for research tools or data exports

Filter the development pipeline

Reset

7 trials match this view; 9 reported facilities; 9 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 207 across 7 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

20223
20241
20263

Current indexed registry status

Recruiting2
Active, not recruiting2
Completed2
Unknown status1

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Milestones to investigate

The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.

For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.

Matching trial records

7 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

NCT05243329

Treatment Resistant Disorders · Post Traumatic Stress Disorder
Halucenex Life Sciences Inc.

PHASE2

Unknown status

Registry updated 2023-06-29

20

ESTIMATED

2022-10-03
2023-10-30
2023-12-30
A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout

NCT05163496

Burnout, Caregiver · Burnout, Professional · COVID-19 · Depression · Post Traumatic Stress Disorder · Moral Injury
University of Washington

PHASE3

Completed

Registry updated 2025-03-18

30

ACTUAL

2022-03-03
2023-12-30
2024-06-30
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

NCT05312151

Post Traumatic Stress Disorder
COMPASS Pathways

PHASE2

Completed

Registry updated 2025-06-13

22

ACTUAL

2022-06-10
2024-02-12
2024-02-12
Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy

NCT06407635

Post Traumatic Stress Disorder
Johns Hopkins University

PHASE1

Active, not recruiting

Registry updated 2026-06-22

20

ESTIMATED

2024-06-07
2026-03-09
2027-05
A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)

NCT06902974

Post Traumatic Stress Disorder · PTSD
Sunstone Medical

PHASE2

Recruiting

Registry updated 2026-07-01

70

ESTIMATED

2026-05-23
2027-11
2028-05
Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial

NCT06386003

Post Traumatic Stress Disorder · PTSD · Chronic PTSD
Unity Health Toronto

PHASE2

Active, not recruiting

Registry updated 2026-10-06

15

ESTIMATED

2026-06-01
2028-01
2028-06
A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)

NCT07104916

Post Traumatic Stress Disorder · Depression - Major Depressive Disorder
Anthony P King

PHASE2

Recruiting

Registry updated 2026-10-19

30

ESTIMATED

2026-09-01
2029-09
2029-12

Reported research facilities

Halucenex Life Sciences Inc.Windsor, Nova Scotia, Canada · Coordinates available
St. Michael's Hospital, Unity Health TorontoToronto, Ontario, Canada · Coordinates available
Kings College London, Institute of Psychiatry, Psychology and NeurologyLondon, United Kingdom · Coordinates available
Icahn School of Medicine at Mount SinaiNew York, New York, United States · Coordinates available
Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States · Coordinates available
Sunstone Medical, PCRockville, Maryland, United States · Coordinates available
Sunstone TherapiesRockville, Maryland, United States · Coordinates available
The Ohio State University Medical CenterColumbus, Ohio, United States · Coordinates available
University of WashingtonSeattle, Washington, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.